Research Title: A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (CHROMA)
Sponsor: Hoffmann-La Roche
Principal Investigator: Robert A. Stoltz, M.D., Ph.D.
Description: This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Start Date: January 2015
Project Personnel: Leslie Marcus, CCRC; Halie Sklanka, CRC
Location(s): Marietta, 833 Campbell Hill Street, Suite 300, Marietta, GA 30060